Discover
Our News
Scaling Up Fermentation with a Multi-Bioreactor Installation from 50 to 5,000 L
Boccard is developing a multi-bioreactor installation to support fermentation scale-up from 50 to 5,000 L. Independent and cascade operating modes combine with integrated automation to support process development and larger-scale production.
How to Increase Cosmetics Production Efficiency: Boccard’s Integrated Process Solution for Tatra Spring
As cosmetics production scales up, increasing the capacity of individual pieces of equipment is no longer enough. This is because automation, production flexibility, efficient material and product flows, effective CIP cleaning, and the integration of all process stages into a single system become increasingly important.
Tatra Spring, a cosmetics manufacturer belonging to the international Intercos Group, faced the challenge of moving from production based on standalone equipment to a fully integrated production environment.
Bioreactors Open Day 2026 – Thank You for Joining Us!
Discover the key topics from Bioreactors Open Days 2026: 50 L, 500 L, and 5,000 L bioreactors, bioprocess scale-up, and biomanufacturing automation.
Monoclonal Antibodies: Uses, Production and Recent Advances
Discover how monoclonal antibodies work, the conditions they can help treat and how they are produced at scale. Explore recent clinical advances and Boccard’s capabilities in process equipment, utilities integration and GMP project delivery.
Biopharmaceutical Manufacturing For Neurological Therapies: Building The Manufacturing Backbone For Next-Generation Treatments
Neurological biologics require scalable cell culture, purification, clean utilities and GMP-ready facilities for reliable commercial production at global scale.
Detecting Deviations from CIP Standards: Preventing Caustic Soda Overconsumption Through Industrial Data, Track Advance® and Process Expertise
An unusual increase in caustic solution consumption was detected at a CIP station. Thanks to historical data in Track Advance® and Boccard’s process expertise, the source of the deviation was identified and its impact quantified; the avoided excess consumption was estimated at 255 m³/year.
Boccard UK awarded a 4-year contract for Sizewell C
Boccard UK has been awarded a major contract to deliver critical Pools, Tanks, and Sumps (PTS) scope elements for the Sizewell C nuclear power station
Immunoglobulin Production for Rare Autoimmune Diseases
As demand for immunoglobulin therapies grows across rare autoimmune diseases, manufacturers must expand plasma fractionation capacity while maintaining strict GMP and viral safety standards. This case study shows how Boccard delivered a large-scale, integrated immunoglobulin production facility designed to support long-term IVIg supply.
Advanced process solutions for oncology pharmaceutical manufacturing
Modern process solutions enable the safe, efficient, and GMP-compliant production of oncology drugs. Thanks to advanced pharmaceutical technologies, it is possible to scale up production while maintaining the highest quality and full process control.
Boccard at PCI Days 2026 – Meet Us in Warsaw
From June 16–18, 2026, Boccard will take part in PCI Days 2026, held at the EXPO XXI Exhibition Center in Warsaw.
Trusted Engineering Partner for Biotech Driven Animal Health Production
As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.
Boccard in Latin America: Meet Us at Expo Pack 2026
Boccard in Latin America at Expo Pack 2026 | Process & Life Sciences Solutions For over thirteen years, Boccard has been strengthening its presence in
Boccard at CEBioFORUM 2026 | Warsaw
Boccard at the Pitch Sessions during CEBioForum 2026 Meet the innovators shaping the future of life sciences. At this year’s CEBioForum 2026, taking place onApril
Industrial Insulin Production Explained: Technology, Purification and Aseptic Formulation
As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.
Scaling up GLP-1 Production to Meet Global Demand: Boccard’s Contribution to a High-Growth Therapeutic Segment
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.
Fermentation for Food & Ingredients: Pilot to Industrial-Scale Lactic Acid Production from Molasses
Discover how lactic acid for food ingredients (E270) is produced by fermenting molasses with lactic‑acid‑producing microorganisms, then readied for scale with inline pH and DO, CIP/SIP and hygienic utilities in a compact footprint. TEKINBIO™ with Track Advance delivers optimised aeration, mixing and thermal control with recipe governance and lot‑to‑lot comparison, creating a reproducible and traceable path to industrialisation.
Fermentation in Cosmetics: Innovative and Active-Delivering Biocarriers
Discover how cosmetic biocarriers are produced through fermentation: combining biosurfactant inputs with biopolymer matrices to encapsulate actives and deliver controlled release. Boccard supplied 2×300 L pilot bioreactors as plug‑and‑connect skids (gas handling, dosing, CIP/SIP), creating a reproducible pilot environment that simplifies recipe iteration and scale‑up. With TEKINBIO™ and Track Advance, teams gain tighter control of aeration, mixing, and temperature, plus lot‑to‑lot comparison for reliable industrialisation.
Boccard at CFIA 2026 France
Discover Boccard’s smart technologies for energy efficiency and process excellence in the Food Industry. At Boccard, we help food manufacturers reduce energy costs, boost productivity,
RMH: Malting Project in Mexico
A global brewing leader launched a strategic investment in Mexico to strengthen its supply chain and sustainability goals. The initiative included a malting facility project designed to support local beer production and reduce dependency on imported malt.
RMH: Where Tradition Meets Innovation – Carlsberg Huê Expansion
In the heart of Vietnam, in the city of Huê, Carlsberg took a bold step: expanding its brewery to become a symbol of modernity in the region. The challenge? Increase efficiency and introduce cutting-edge technologies in raw material handling while preserving the local character of production.
Boccard and Thorizon sign strategic cooperation to advance decarbonation and molten-salt reactor development in Europe
Boccard and Thorizon sign strategic cooperation to advance decarbonation and molten-salt reactor development in Europe Partnership to engineer pump qualification loop and prepare pipework for
You have a project ?
Our Customers
They trust us
